亨廷顿病中类淋巴相关磁共振成像标志物的多模态特征:一项多队列回顾性研究
该研究分析了3个大型回顾性亨廷顿病(HD)队列中880名参与者的2731次MRI检查,按HD综合分期系统将HD基因携带者分为0至3期。结果显示,左侧ALPS指数在较晚期阶段降低,皮层下EPVS体积分数在HD中升高,且ALPS与EPVS可改善对HD进展的预测。
要点
- 左侧ALPS指数在HD较晚期阶段低于对照,效应量小到中等。
- 皮层下EPVS体积分数在HD 1至3期较对照升高,白质EPVS体积分数在3期降低。
- ALPS与EPVS在CAG-年龄乘积评分和纹状体体积之外改善对HD进展的预测。
核心结论
- 多模态MRI显示基于MRI的类淋巴替代标志物随HD分期出现改变,效应量小到中等。
- DTI-ALPS与EPVS指标可提供从常规影像方案获得的互补性无创HD病理指标。
研究设计与样本
- 多队列回顾性研究,分析3个大型回顾性HD队列中880名参与者的2731次MRI检查。
- HD基因携带者按HD综合分期系统分为0至3期。
- 评估沿血管周围间隙的扩散张量图像分析(DTI-ALPS)指数和MRI可见的扩大的血管周围间隙(EPVS)。
- 采用线性混合效应模型检验组间差异及与运动、认知和功能指标的关联。
- 采用似然比检验评估其在既定影像、遗传和人口学变量之外的额外解释价值。
主要发现
- 与对照相比,左侧ALPS指数在较晚期阶段降低:1期−3.71%(Cohen's d:−0.25),2期−4.33%(Cohen's d:−0.31),3期−6.43%(Cohen's d:−0.46),均p < 0.05,且独立于人口学和临床变量。
- 皮层下EPVS体积分数在HD中升高(1至3期:+49.9%至+63.7%,Cohen's d:0.47至0.55,p < 0.0001)。
- 白质EPVS体积分数在3期降低(−13.8%,Cohen's d:−0.21,p < 0.05)。
- 较低的ALPS指数与较高的运动损害相关(p < 0.0001),与降低的功能能力相关(p < 0.01)。
- ALPS和EPVS均在CAG-年龄乘积评分和纹状体体积之外改善对复合HD进展的预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To characterize magnetic resonance imaging (MRI)-based glymphatic surrogates in Huntington's disease (HD) using MRI measures of perivascular diffusivity and structural perivascular alterations across multiple large cohorts. Methods We analyzed 2,731 MRI sessions from 880 participants across 3 large retrospective HD cohorts. HD gene carriers were grouped by the HD Integrated Staging System into stage 0 to 3. We assessed the diffusion tensor image analysis along the perivascular space (DTI-ALPS) index and MRI-visible enlarged perivascular spaces (EPVS). Linear mixed-effects models examined group differences and associations with motor, cognitive, and functional measures. Likelihood ratio tests evaluated their added explanatory value beyond established imaging, genetic, and demographic variables. Results Left ALPS indices were lower at more advanced disease stages (stage 1: −3.71%, Cohen's d: −0.25; stage 2: −4.33%, Cohen's d: −0.31; Stage 3: −6.43%, Cohen's d: −0.46; all p < 0.05) compared with controls, independent of demographic and clinical variables. EPVS burden showed region-specific patterns, with subcortical EPVS volume fraction increased in HD (stage 1–3: +49.9% to +63.7%, Cohen's d: 0.47 to 0.55, p < 0.0001), whereas white matter EPVS volume fraction decreased at Stage 3 (−13.8%, Cohen's d: −0.21, p < 0.05). Lower ALPS indices correlated with higher motor impairment (p < 0.0001) and reduced functional capacity (p < 0.01). Both ALPS and EPVS improved prediction of composite HD progression beyond CAG-Age Product Score and striatal volume. Interpretation Multimodal MRI revealed stage-dependent alterations in MRI-based glymphatic surrogates with low to moderate effect sizes. These findings suggest that DTI-ALPS and EPVS metrics offer complementary, noninvasive indicators of HD pathology derivable from routine imaging protocols. ANN NEUROL 2026;100:1055–1067
引用
- Annals of Neurology:Multimodal Characterization of Glymphatic‐Related Magnetic Resonance Imaging Markers in Huntington's Disease: A Multi‐Cohort Retrospective Study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。